These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28486240)

  • 1. Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.
    Michaud TL; High R; Charlton ME; Murman DL
    Alzheimer Dis Assoc Disord; 2017; 31(3):209-217. PubMed ID: 28486240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross sectional observational study on the societal costs of Alzheimer's disease.
    Mesterton J; Wimo A; By A; Langworth S; Winblad B; Jönsson L
    Curr Alzheimer Res; 2010 Jun; 7(4):358-67. PubMed ID: 19939223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
    Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
    Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
    Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence in Alzheimer's disease and service use costs, quality of life, and caregiver burden: the DADE study.
    Jones RW; Romeo R; Trigg R; Knapp M; Sato A; King D; Niecko T; Lacey L;
    Alzheimers Dement; 2015 Mar; 11(3):280-90. PubMed ID: 25074342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging from clinical endpoints to estimates of treatment value for external decision makers.
    Zhu CW; Leibman C; Townsend R; McLaughlin T; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    J Nutr Health Aging; 2009 Mar; 13(3):256-9. PubMed ID: 19262963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between caregiver burden and caregiver health-related quality of life in Alzheimer disease.
    Bell CM; Araki SS; Neumann PJ
    Alzheimer Dis Assoc Disord; 2001; 15(3):129-36. PubMed ID: 11522930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.
    Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
    Int Psychogeriatr; 2016 Feb; 28(2):247-59. PubMed ID: 26307191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study.
    Miller EA; Rosenheck RA; Schneider LS
    Curr Alzheimer Res; 2010 Jun; 7(4):348-57. PubMed ID: 19715552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
    BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey.
    Montgomery W; Goren A; Kahle-Wrobleski K; Nakamura T; Ueda K
    BMC Geriatr; 2018 Jun; 18(1):141. PubMed ID: 29898679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregiver burden, health utilities, and institutional service costs among community-dwelling patients with Alzheimer disease.
    Miller EA; Rosenheck RA; Schneider LS
    Alzheimer Dis Assoc Disord; 2010; 24(4):380-9. PubMed ID: 20625266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of costs of care for patients with Alzheimer's disease.
    Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
    Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
    Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
    J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of patient function and dependence on costs of care in Alzheimer's disease.
    Zhu CW; Leibman C; McLaughlin T; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    J Am Geriatr Soc; 2008 Aug; 56(8):1497-503. PubMed ID: 18662215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with quality of life in patients with Alzheimer's disease.
    Barbe C; Jolly D; Morrone I; Wolak-Thierry A; Dramé M; Novella JL; Mahmoudi R
    BMC Geriatr; 2018 Jul; 18(1):159. PubMed ID: 29986669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.